patent/JP-2005535596-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005535596-A

Outgoing Links

Predicate	Object
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
filingDate	2003-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2005-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	JP-2005535596-A
titleOfInvention	Protein kinase inhibitor
abstract	A compound of general formula I, or a pharmaceutically acceptable salt, hydrate, solvate, crystalline form or diastereomer thereof is described. Also described are methods of treating protein kinase related conditions using compounds of Formula I.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016506418-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011510948-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016534153-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4772690-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006514685-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018158931-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011093930-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9139560-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014148522-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364238-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10532994-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014520767-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007513093-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018024670-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10246438-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016506417-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10231966-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015164925-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4777065-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9732046-B2
priorityDate	2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0224681-A2
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58717117 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421248359 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466675970 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413520303 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135511977

Total number of triples: 62.